Form 4: Oscar Health COO Steven Wolin Reports Stock Transactions

Sentiment:

SEC Form 4


Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the acquisition and disposition of Class A Common Stock and Restricted Stock Units.

Summary

  • On June 4, 2024, Steven Wolin, the Chief Operating Officer of Oscar Health, Inc., filed a Form 4 detailing transactions in the company's Class A Common Stock.
  • Wolin acquired shares through the vesting of Restricted Stock Units (RSUs) and disposed of shares to cover tax obligations.
  • On June 1, 2024, Wolin acquired a total of 36,364 shares of Class A Common Stock through the vesting of RSUs.
  • On June 3, 2024, Wolin sold 18,607 shares at a weighted average price of $19.46.
  • On June 4, 2024, Wolin sold 486 shares at a weighted average price of $19.09.
  • Following these transactions, Wolin directly owns 64,830 shares of Class A Common Stock and 263,019 Restricted Stock Units.
  • The sales were executed under a pre-arranged Rule 10b5-1 trading plan to cover tax obligations related to the vesting of equity awards.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are part of a pre-planned strategy, but any insider selling can create some uncertainty.

Positives

  • The vesting of RSUs indicates that Wolin is accumulating more equity in the company.
  • The use of a 10b5-1 trading plan suggests a structured and transparent approach to stock sales.

Negatives

  • The sale of shares, even for tax purposes, could be perceived negatively by some investors.

Risks

  • Continued stock sales by insiders could create downward pressure on the stock price.
  • Changes in tax laws could affect the need for such sales in the future.

Industry Context

Insider transactions are closely watched in the healthcare industry to gauge executive sentiment and potential future performance. The use of 10b5-1 plans is common for managing tax obligations and avoiding accusations of trading on inside information.

Comparison to Industry Standards

  • Comparing Wolin's transactions to those of executives at similar health insurance companies like UnitedHealth Group (UNH) or Humana (HUM) could provide context.
  • For example, large, pre-planned sales to cover taxes are common, but the size and frequency can be compared to industry norms.
  • The vesting schedules of RSUs are also fairly standard across the industry, typically vesting over 3-year periods.

Stakeholder Impact

  • Shareholders may react to the stock sales, although the pre-planned nature mitigates potential concerns.
  • Employees holding stock options or RSUs may be sensitive to stock price fluctuations.

Key Dates

DateDescription
April 21, 2024Date of Power of Attorney execution.
February 27, 2023Date prior to which the Rule 10b5-1 instruction letter was entered into.
June 1, 2022Start date for vesting of some restricted stock units over a three-year period in 12 equal quarterly installments.
June 1, 2023Start date for vesting of some restricted stock units over a three-year period in 12 equal quarterly installments.
June 1, 2024Date of RSU vesting and acquisition of Class A Common Stock.
June 1, 2024Start date for vesting of some restricted stock units over a three-year period in 12 equal quarterly installments.
June 3, 2024Date of sale of Class A Common Stock.
June 4, 2024Date of sale of Class A Common Stock and filing of Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.